A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients-Reference-Cited by-同舟云学术

A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients

Published:2010-10-07 Issue:11-12 Volume:32 Page:1315-1322
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Anty R.,Iannelli A.,Patouraux S.,Bonnafous S.,Lavallard V. J.,Senni-Buratti M.,Ben Amor I.,Staccini-Myx A.,Saint-Paul M.-C.,Berthier F.,Huet P.-M.,Le Marchand-Brustel Y.,Gugenheim J.,Gual P.,Tran A.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2010.04480.x/fullpdf

Reference34 articles.

1. Diagnosis and therapy of nonalcoholic steatohepatitis;Torres;Gastroenterology,2008

2. Long-term follow-up of patients with NAFLD and elevated liver enzymes;Ekstedt;Hepatology,2006

3. The natural history of nonalcoholic fatty liver disease: a population-based cohort study;Adams;Gastroenterology,2005

4. Hepatic histology in obese patients undergoing bariatric surgery;Machado;J Hepatol,2006

5. Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects;Huang;Obes Surg,2007

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MASLD- Global prevalence, pathophysiological processes and management pathways- tackling a complex problem;Gastroenterology & Hepatology: Open access;2024-07-25

2. Nonalcoholic fatty liver disease: What comes before and what are the consequences?;Chronic Complications of Diabetes Mellitus;2024

3. Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese;Cell Reports Medicine;2023-11

4. Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease;Metabolites;2023-10-29

5. Non-alcoholic Steatohepatitis in Asians: Current Perspectives and Future Directions;Cureus;2023-08-02